Related Experiment Video

Updated: Sep 24, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer

Çağdaş Aktan1, Çağ Çal2, Burçin Kaymaz3

  • 1Department of Medical Biology, Faculty of Medicine, Beykent University, Istanbul, Turkey; Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.

Life Sciences
|May 4, 2022
PubMed
Abstract

Insights

This study identified specific microRNAs (miRNAs) that are upregulated in castration-resistant prostate cancer (CRPC). Inhibiting these miRNAs reduced prostate cancer cell proliferation and androgen receptor levels, suggesting a new therapeutic strategy for CRPC.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Cancer Biology

Background:

  • Androgen receptor (AR) signaling is crucial in prostate cancer (PC) development and progression.
  • MicroRNAs (miRNAs) are increasingly recognized as key regulators of gene expression and are often dysregulated in PC.
  • Targeting AR signaling represents a significant therapeutic strategy for PC.

Purpose of the Study:

  • To identify and investigate differentially expressed miRNAs that target the androgen receptor (AR) in prostate cancer.
  • To explore the role of specific miRNAs in the progression of castration-resistant prostate cancer (CRPC).
  • To evaluate the potential of miRNAs as therapeutic targets for PC treatment.

Main Methods:

  • In silico analysis to identify miRNAs targeting AR.
  • Quantitative real-time PCR (qPCR) to measure miRNA expression levels.
  • Western blot and apoptosis assays to investigate molecular mechanisms.
  • Transfection with anti-miRs to assess functional impact on PC cells.

Main Results:

  • Several miRNAs were found to be differentially regulated in CRPC cells compared to androgen-dependent (AD) cells.
  • miR-625-5p and miR-874-3p showed significant upregulation in CRPC cells.
  • Increased expression of AR and prostate-specific antigen was observed in PC cells.
  • Inhibition of specific miRNAs using anti-miRs suppressed PC cell proliferation and reduced AR protein levels.

Conclusions:

  • miR-625-5p and miR-874-3p are potentially involved in prostate cancer progression and are differentially regulated in CRPC.
  • These findings offer novel insights into the molecular mechanisms of CRPC.
  • miRNA-based therapies may represent a promising alternative strategy for preventing CRPC development.
Keywords:
Androgen receptorCastration resistant prostate cancerProstate specific antigenmicroRNA-625-5pmicroRNA-874-3p

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.7K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K